Kardigan’s IPO Lands $400M for Drugs That Get to Root Causes of Heart Diseases
Kardigan was capable of upsize its IPO, elevating more money for 3 drug candidates in mid-stage scientific improvement for cardiovascular ...
Tag: 400M
Generate Biomedicines’ IPO Brings In $400M for Pivotal Tests of Severe Asthma Drug
Flagship Pioneering-founded Generate Biomedicines goals to supply much less frequent injections in comparison with a blockbuster bronchial asthma drug from ...
Capital Rx Rebrands as Judi Health After Securing $400M Investment
Capital Rx, a transparent pharmacy benefit manager, has secured a $400 million investment and is rebranding under the name Judi ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!